Cardinal Health, Inc.
CAH - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$63.08B
Close$
Earnings Call Q1 2027
November 5, 2026 - AI Summary
Strong Q1 performance + operating leverage (good / quantified): Total company revenue +5% to $67.5B; gross profit +12% to $2.6B; SG&A +9% to $1.6B. Operating income grew +17% to ~$1.0B (a milestone: first time achieving ~$1B operating income in a quarter). Diluted EPS up 28% to $3.26 after a $500M accelerated share repurchase completed in the quarter; cash generation remained strong with $1.6B adjusted free cash flow.
Fiscal 2027 outlook raised (good / explicit forecasts): Non-GAAP diluted EPS raised to $12.80–$13.00 (from $12.40–$12.60), implying 17%–19% growth vs ex-tariff refund adjusted FY26 EPS of $10.95. Full-year expectations also updated by segment:
- Pharma: Revenue growth expected 3%–5% (unchanged), but segment profit growth raised to 10%–12% (from 8%–11%).
- GMPD (global med products & distribution): Revenue 2%–4% (unchanged). Segment profit guidance not changed, but management noted petroleum costs (Iran-related) push GMPD segment profit toward the low end of $200M–$220M.
- Other (at-Home, Nuclear & Precision Health, OptiFreight): Revenue growth increased to 12%–14% (from 11%–13%) and profit growth raised to 17%–20% (from 15%–18%).
Quarterly cadence expectations (surprising / timing-driven): Management expects earnings to moderate in Q2 and Q3, then strengthen in Q4—driven by laps of customer renewals timing and lapping the Solaris acquisition in the middle of Q2, rather than deterioration in underlying demand.
Exclusive for Stockcircle Pro members
Sign up
$617.53
122.6% upside
Current Fair Value
122.6% upsideUndervalued by 122.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $63.08 Billion |
|---|---|
| Enterprise Value | $68.17 Billion |
| Annual dividend | $2.05 |
| Dividend yield | 0.76% |
| Earnings per Share | $7.27 |
| Beta | 0.52 |
| Outstanding Shares | 232,000,000 |
Return
| Return on Equity | -59.45% |
|---|---|
| Return on Assets | 2.99% |
| Return on Invested Capital | 18.95% |
Valuation & Multiples
| P/E Ratio | 34.97 |
|---|---|
| PEG | 53.92 |
| Price to Sales | 0.25 |
| Price to Book Ratio | -23.11 |
| Enterprise Value to Revenue | 0.27 |
| Enterprise Value to EBIT | 26.86 |
| Enterprise Value to Net Income | 39 |
| Total Debt to Enterprise | 0.15 |
| Debt to Equity | -3.45 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 5, 2026
EPS
$3.26
Est. $2.94Revenue
$67.51 B
Est. $66.67 BNext Earnings Call
Expected Date
February 4, 2027
EPS Estimate
$3.17
Consensus analyst estimateRevenue Estimate
$68.32 B
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 99.88% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 12.58%▼ 75.76% |
|---|---|
| Total Invested | $6.60B▼ 86.66% |
| Investors Holding | 805▼ 745.00% |
About Cardinal Health, Inc.
63,900 employees
CEO: Jason Hollar
Cardinal Health, Inc. functions as a comprehensive provider of healthcare services and products, extending its reach across the United States, Canada, Europe, Asia, and other international markets. The company delivers tailored solutions...